M13 Phage ssDNA Production via Engineered Terminator Sequences

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Conventional methods for producing single-stranded DNA (ssDNA) result in varying lengths, necessitating labor-intensive and costly purification steps to achieve uniform length.

Innovation Solution

The use of engineered initiator and terminator sequences from a filamentous bacteriophage, combined with a DNA sequence of interest, to produce ssDNA of uniform length, where the engineered nucleic acid comprises an engineered initiator sequence and an engineered terminator sequence, allowing for tight regulation of DNA production.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional methods are used to produce ssDNA, then ssDNA of varying lengths can be obtained, but labor-intensive and expensive purification steps are required to achieve uniform length

Engineering Contradiction:
ImprovessDNA length uniformityVSAvoidproduction efficiency
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent applies preliminary action by incorporating engineered initiator and terminator sequences directly into the DNA template before replication. These sequences pre-determine the exact length of ssDNA to be synthesized, preventing the need for subsequent purification steps to achieve uniform length. The terminator sequence is positioned upstream of the initiator sequence in the template, creating a self-limiting replication system that inherently produces monodisperse ssDNA.

Inventive Principle:
Principle #10Preliminary action

2Manufacturing precision

If conventional methods are used to produce ssDNA, then ssDNA can be produced, but purification steps are labor-intensive and expensive

Engineering Contradiction:
ImprovessDNA length consistencyVSAvoidpurification complexity
Core Design Contradiction:
Manufacturing precisionVSEase of manufacture

Solution Approach 1:

The patent implements self-service by designing a self-regulating replication system where the engineered initiator and terminator sequences automatically control the replication process. The system serves itself by using the terminator sequence to halt replication at the precise location, eliminating the need for external purification interventions. This self-limiting mechanism inherently produces uniform-length ssDNA without requiring labor-intensive purification protocols.

Inventive Principle:
Principle #25Self-service

3Manufacturing precision

If engineered initiator and terminator sequences are used, then ssDNA of uniform length can be produced, but the system requires precise sequence design and positioning

Engineering Contradiction:
ImprovessDNA length uniformityVSAvoidsequence engineering complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent applies segmentation by dividing the replication control function into two distinct, modular elements: an initiator sequence that starts replication and a terminator sequence that ends it. This segmentation allows independent optimization of each element's function while maintaining overall system simplicity. The initiator and terminator can be designed as separate modules with specific sequences (e.g., using restriction enzyme sites like BamHI and XhoI for cloning), reducing the complexity of designing and positioning them within the larger DNA template.

Inventive Principle:
Principle #1Segmentation

Data Source

PatentUS11976270B2Optimization of circular single stranded DNA using M13 phage
Publication Date: 2024.05.07 MASSACHUSETTS INST OF TECH
  • US11976270B2 patent drawing
  • US11976270B2 patent drawing
  • US11976270B2 patent drawing

AI summary

Provided herein, in some aspects, are methods and compositions for producing single-stranded DNA (ssDNA) having uniform length.